Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
Key Details
- 1Aidoc raises $150 million in Series E round, led by Goldman Sachs, with support from NVentures (Nvidia), SoftBank, and General Catalyst.
- 2Total funding now exceeds $500 million.
- 3The funding will advance Aidoc’s CARE Foundation Model, a flexible AI solution able to perform a variety of imaging tasks.
- 4Aidoc technologies are deployed in nearly 2,000 hospitals, have analyzed over 110 million patient cases, and support care for 60 million patients annually.
- 5The company holds the most FDA clearances for computer-aided detection in radiology.
- 6Aidoc aims to enhance end-to-end AI workflows, including automated draft imaging report creation.
Why It Matters
This funding positions Aidoc to further drive innovation and adoption in radiology AI, expanding indications, and integration into enterprise clinical workflows. The scale and backing from major tech and investment firms may accelerate the availability and capabilities of imaging AI globally.
Source
Radiology Business
Related News
•Radiology Business
AI Model Outperforms Radiologists in Early Pancreatic Cancer Detection
REMOD, a new AI model, detects pancreatic cancer on CT scans much earlier and more accurately than radiologists.
•AuntMinnie
AI-Driven Mammogram Analysis Boosts Cardiovascular Risk Prediction in Women
AI quantification of breast arterial calcifications (BACs) on mammograms enhances prediction of cardiovascular events beyond traditional risk models.
•Radiology Business
AI Model Identifies Colorectal Cancer on Routine Noncontrast CT Scans
Researchers introduce the COCA AI tool to detect colorectal cancer opportunistically on routine noncontrast CT scans.